February 2008
From Kidney Cancer Resource
To Go back To Kidney Cancer Articles
When | Media & Link on KCR (KC) | Details | Category |
28-Feb-08 | Interactive Investor (KC) | Novartis to seek cancer drug Everolimus clearance worldwide | Novartis / Everolimus |
29-Feb-08 | PharmaTimes (KC) | Bayer hopes antithrombotic Xarelto will 'transform' the firm | Nexavar |
28-Feb-08 | MedPage (KC) | Clear Benefit from Everolimus Brings Kidney Cancer Trial to a Halt | Everolimus |
28-Feb-08 | Reuters (KC) | Novartis kidney cancer drug clears key hurdle | Novartis / Everolimus |
28-Feb-08 | Stratford Herald (KC) | CANCER DRUG DISPUTE REFERRED TO MINISTER | Sutent |
28-Feb-08 | Wiltshire Network (KC) | Cancer drug refused | Sutent |
28-Feb-08 | PharmaTimes (KC) | Novartis' Everolimus shines in Phase III kidney cancer trial | Novartis / Everolimus |
27-Feb-08 | GE&B News (KC) | Everolimus (RAD001) Significantly Extends Progression-Free Survival in Advanced Kidney Cancer Patients After Failure of Other Targeted Therapy | Everolimus / RAD001 |
27-Feb-08 | Houston Chronical (KC) | A study published in a major medical journal linked a group of anemia drugs to a greater risk of death, | Anaemia / Kidney Cancer |
27-Feb-08 | FDANews (KC) | Oxford Biomedica to Receive Milestone Payment From Sanofi | TRIST / Oxford Biomedica / TroVax |
27-Feb-08 | Matria (KC) | Statins May Reduce Risk of Kidney Cancer | Statins |
26-Feb-08 | PharmaTimes (KC) | Antisoma pleases with strong first-half sales | AS1409 / Antisoma |
24-Feb-08 | The Gazette (Montreal) (KC) | Eye-cancer treatment shows promise | 17-AAG |
22-Feb-08 | Las Vegas Sun (KC) | Las Vegas doctor’s cancer drug accepted for human testing | CD26 |
22-Feb-08 | The News and Observer (KC) | Antigenics Reports Fourth Quarter and Year-End 2007 Financial Results | Oncophage |
22-Feb-08 | 680 News (KC) | Canada has access to new treatment for kidney cancer | Torisel |
22-Feb-08 | ScienceDaily (KC) | Immune System Versus Solid Tumor: An Example Of The Immune System Winning | HCT |
20-Feb-08 | Oxford Biomedica | Oxford Biomedica Announces Data Safety Monitoring Board Recommendation to Continue TROVAX® Phase III Trist Study | TRIST / Oxford Biomedica / TroVax |
19-Feb-08 | Newsmax (KC) | NAC Protects Kidneys During CT Scans | CT Scan |
19-Feb-08 | MedPage (KC) | ASCO GU: Bevacizumab-Based Duo Retards Metastatic Kidney Cancer | Avastin |
18-Feb-08 | Boston Globe (KC) | Bayer stops late-stage Nexavar trial | Nexavar / Kidney Cancer |
18-Feb-08 | Manchester Evening News (KC) | Ben's a shining star | Wilms tumour |
16-Feb-08 | LA Times (KC) | Cancer and the bacterial connection | Kidney Cancer |
15-Feb-08 | Telegraph (KC) | Extra two stones boosts risk of cancer | Bladder Cancer / BMI |
15-Feb-08 | AP (KC) | Being Overweight May Raise Cancer Risk | Kidney Cancer / BC |
14-Feb-08 | Matria (KC) | Excess Body Weight Raises Cancer Risk | ]]Kidney Cancer / BMI |
14-Feb-08 | MedPage (KC) | ASCO GU: Partial Nephrectomy Underused for Small Kidney Tumors | Nephrectomy |
14-Feb-08 | Oxford Mail (KC) | Danes saved patient’s bacon’ | Nexavar |
14-Feb-08 | Earth Times (KC) | Accelerated Community Oncology Research Network, Inc. (ACORN), Initiates a Phase 2b Metastatic Breast Cancer Trial in Cooperation With Bayer and Onyx | Bayer / Avastin |
14-Feb-08 | MedPage (KC) | ASCO GU: Sunitinib Cardiotoxicity Unexpectedly High in Real-World Use | Sutent |
14-Feb-08 | Forbes (KC) | Kidney Cancer Drug Linked to Higher Rate of Heart Problems | Sutent |
14-Feb-08 | i/c Wales (KC) | Cancer drug shock | Sutent |
13-Feb-08 | Reuters (KC) | Partial kidney removal under-used for small tumors | Nephrectomy |
13-Feb-08 | Denver Channel (KC) | Researchers Find Ways To Kill Cancer New Weapon Could Treat Tumors Without Surgery | Kidney Cancer |
13-Feb-08 | PRnews (KC) | Second Phase III Study of Avastin in 1st Line Metastatic Breast Cancer Meets its Primary Endpoint | Avastin |
13-Feb-08 | Toronto Sun (KC) | Patients 'forced to foot bill' | Sutent / Nexavar |
13-Feb-08 | Uro Today (KC) | Cytoreductive Nephrectomy for T4NxM1 Renal Cell Carcinoma: | Kidney Cancer / Cytoreductive |
13-Feb-08 | Reuters (KC) | Pfizer's Sutent causes heart failure in some: study | Sutent |
12-Feb-08 | The Messenger (KC) | CHHS student committed to fight against cancer | Wilms Tumour |
12-Feb-08 | Bangkok Post (KC) | Alongside his work on breast cancer research, Ullrich has also made substantial findings in the fields of diabetes and kidney cancer research, .... | Kidney Cancer |
11-Feb-08 | MIMS Ireland (KC) | Avastin approved in Europe for first-line treatment of patients with advanced kidney cancer | Avastin |
11-Feb-08 | PharmaLive (KC) | FDA Issues Special Protocol Assessment (SPA) for Pivotal Phase III Trial with CA9-SCAN | F&DA / CA9-SCAN |
11-Feb-08 | CDAPress.com (KC) | Kootenai Cancer Center to test cancer vaccine | TroVax |
09-Feb-08 | Midland News (KC) | 'The miracle exists' | Kidney Cancer |
09-Feb-08/2 | Oxford Mail (KC) | Cancer drug refused: But we'll keep fighting | Sutent |
09-Feb-08 | Oxford Mail (KC) | UPDATE: Cancer drug - I support Sumners | Sutent |
08-Feb-08 | My Desert (KC) | Is your moisturizers killing you? | Kidney Cancer |
08-Feb-08 | Fox News (KC) | Misonix Reports an Increase in Revenues for the Three Months Ending December 31, 2007 | Sonatherm / HIFU / Misonix |
08-Feb-08 | DocGuide (KC) | Sorafenib Plus Low-Dose Interferon-Alpha-2a Shows Clinical Benefit in Metastatic Renal Cell Carcinoma | Nexavar / Interferon |
08-Feb-08 | i/c Coventry (KC) | Rugby man had only a year to live - but is now thriving thanks to cancer drug.... | Sutent |
07-Feb-08 | Tamil Star (KC) | What are the most common types of cancer? | Kidney Cancer |
07-Feb-08 | Leamington Observer (KC) | Cancer drug row | Sutent |
06-Feb-08 | WRAL (KC) | Heat Can Replace Scalpel in Attacking Tumors | RFA / Kidney Cancer |
05-Feb-08 | Medical Lead (KC) | Carol Vorderman Supports Kidney Cancer Charities UK Survey | James Whale Fund / Bayer / Pfizer |
05-Feb-08 | Innovations Report (KC) | UCD scientist makes an advance in the war against cancer cells | Kidney Cancer |
04-Feb-08 | CNW Group (KC) | NEXAVAR the Only Drug Therapy Proven to Significantly Improve Overall Survival | Nexavar / Kidney Cancer |
04-Feb-08 | Science Direct (KC) | Resection of Renal Cell Cancer Metastases: Where Do We Stand in 2008 | Kidney Cancer |
04-Feb-08 | South Wales Evening Post (KC) | LEGAL FIGHT FOR LIFE? | Sutent |
04-Feb-08 | Western Mail (KC) | Grandmother denied Sutent | Sutent |
02-Feb-08 | MyWestTexas (KC) | Donated hair comes from the Hart - Fund Raiser | Fund Raisers |
02-Feb-08 | Kenilworth Weekly News (KC) | Man has to travel to Surrey for treatment | Sutent |
01-Feb-08 | Tulsa World (KC) | OU team finds cancer fighter | Flex-Hets |
01-Feb-08 | Centre Daily Times (KC) | AVEO Initiates Phase 1b Combination Clinical Trial | AV-951 |
01-Feb-08 | The Oklahoman (KC) | Cancer research holds promise | Flex-Hets |
February 2008 | Science Direct (KC) | Treatment Approaches in Renal Cell Carcinoma: Past, Present, and Future Perspectives | Kidney Cancer |
February 2008 | Science Direct (KC) | European Association of Urology Guidelines for Systemic Therapy in Metastatic Renal Cell Carcinoma: What is Recommended and Why.... | Kidney Cancer |
February 2008 | Science Direct (KC) | The Oncologist's View: Targeted Therapies in Advanced Renal Cell Carcinoma.... | Kidney Cancer |
February 2008 | Science Direct (KC) | The Role of Multitargeted Therapies in the Adjuvant Setting in Renal Cell Carcinoma.... | Kidney Cancer |
February 2008 | Ingenta (KC) | Flexible heteroarotinoids (Flex-Hets) exhibit improved therapeutic ratios as anti-cancer agents over retinoic acid receptor agonists | Flex-Hets |
Disclaimer
Kidney Cancer Resource (KCR) is not influenced by sponsors. The information contained herein is not intended as a substitute for the advice of an appropriately qualified and licensed physician or other licensed health care provider. The information provided here is for educational and information purposes only. Early accurate Diagnosis (Dx.) saves lives. Please check with a physician if you suspect you are ill, never ignore Symptoms. To help your health care specialist make an accurate Diagnosis please keep notes of dates, times and details of your Symptoms. We are not offering medical advice nor do we consider links, individuals or articles accessed through this site to be offering medical advice.
E&OE - Errors & Omissions Excepted
As much of the information posted on this Web Site for peoples convenience is of a medical or technical nature, and may be a matter of life or death the E&OE is a Disclaimer showing that to the best of our ability information is accurate and correctly written or transcribed. Before acting on information on this site you are responsible for checking it with your relevant medical team. We can not be held responsible for any Errors & Omissions made; nor for information on links and articles provided in good faith.